Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-16

Clinical Trial Update: Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Temisartan/Amlodipine with Rosuvastatin in hypertension and hyperlipidemia has completed. The update does not include efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Rosuvastatin (rosuvastatin)
  • Temisartan (Temisartan)

Snippet

Sponsor: Yuhan Corporation | Conditions: Hypertension, Hyperlipidemia | Phase 3 | Status: COMPLETED